Dr. VanderVeen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 UCLA Medical Plz Ste 420
Los Angeles, CA 90095Phone+1 310-206-6232
Summary
- Dr. Nathan VanderVeen is based in Los Angeles, CA, and specializes in Medicine/Pediatrics. He completed his residency in Internal Medicine/Pediatrics at UCLA David Geffen School of Medicine/UCLA Medical Center in 2024, after graduating from Western Michigan University Homer Stryker M.D. School of Medicine in 2020. His publications include studies on various medical topics, such as acute intermittent porphyria, metabolic dysfunction-associated steatohepatitis, and renal medullary carcinoma. Some of his works have been cited by other publications, reflecting his contribution to the medical literature.
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine/Pediatrics, 2020 - 2024
- Western Michigan University Homer Stryker M.D. School of MedicineClass of 2020
Certifications & Licensure
- CA State Medical License 2022 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Pediatrics Pediatrics
Publications & Presentations
PubMed
- Acute Intermittent Porphyria in an Adolescent Patient: Diagnostic and Treatment Challenges.Samuel B Rudnick, Nicole E West, Kelly Fong, Simon W Beaven, Nathan T VanderVeen
Cureus. 2024-11-01 - Resolution of metabolic dysfunction-associated steatohepatitis with estradiol in a transgender female: A case report.Athreya Steiger, Nathan T VanderVeen, Esther H Kang, Amy K Weimer
JPGN Reports. 2024-05-01 - 6 citationsCombination Therapy With Bortezomib in Renal Medullary Carcinoma: A Case SeriesAlixandra Ryan, Karine Tawagi, Nathan VanderVeen, Marc R. Matrana, Robert Vasquez
Clinical Genitourinary Cancer. 2021-08-27
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: